4.6 Article

Orphan Nuclear Receptor Estrogen-Related Receptor γ (ERRγ) Is Key Regulator of Hepatic Gluconeogenesis

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 26, Pages 21628-21639

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.315168

Keywords

-

Funding

  1. National Creative Research Initiatives from Korean Ministry of Education, Science and Technology [20110018305]
  2. Korea Healthcare Technology Research and Development Project
  3. National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology [20100019512]
  4. Brain Korea 21 Program fellowship award
  5. Seoul Science fellowship award
  6. NRF [2011-0016454, 2011-0019448]
  7. Ministry of Land, Transport and Maritime Affairs (MLTM), Korea
  8. Korea government (Ministry of Education, Science and Technology)

Ask authors/readers for more resources

Glucose homeostasis is tightly controlled by hormonal regulation of hepatic glucose production. Dysregulation of this system is often associated with insulin resistance and diabetes, resulting in hyperglycemia in mammals. Here, we show that the orphan nuclear receptor estrogen-related receptor gamma (ERR gamma) is a novel downstream mediator of glucagon action in hepatic gluconeogenesis and demonstrate a beneficial impact of the inverse agonist GSK5182. Hepatic ERR gamma expression was increased by fasting-dependent activation of the cAMP-response element-binding protein-CRTC2 pathway. Overexpression of ERR gamma induced Pck1 and G6PC gene expression and glucose production in primary hepatocytes, whereas abolition of ERR gamma gene expression attenuated forskolin-mediated induction of gluconeogenic gene expression. Deletion and mutation analyses of the Pck1 promoter showed that ERR gamma directly regulates the Pck1 gene transcription via ERR response elements of the Pck1 promoter as confirmed by ChIP assay and in vivo imaging analysis. We also demonstrate that GSK5182, an inverse agonist of ERR gamma, specifically inhibits the transcriptional activity of ERR gamma in a PGC-1 alpha dependent manner. Finally, the ERR gamma inverse agonist ameliorated hyperglycemia through inhibition of hepatic gluconeogenesis in db/db mice. Control of hepatic glucose production by an ERR gamma-specific inverse agonist is a new potential therapeutic approach for the treatment of type 2 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available